Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 700
Avg Vol 832
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 16%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Relief Therapeutics Holding SA, a biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases. The company offers SETOFILM/ONDISSOLVE for nausea and vomiting associated with radiotherapy-induced, chemotherapy, and postoperative sequels; ACER-001, a sodium phenylbutyrate for the treatment of urea cycle disorders; and PKU GOLIKE for the dietary management of...

Industry: Biotechnology
Sector: Healthcare
Address:
Avenue de Secheron 15, Geneva, Switzerland
Latest News on RLFTY
No data available.